Psagot Value Holdings’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,176
Closed -$254K 341
2022
Q1
$254K Buy
+2,176
New +$360K 0.06% 177
2021
Q2
Sell
-1,734
Closed -$668K 449
2021
Q1
$668K Sell
1,734
-861
-33% -$388K 0.02% 207
2020
Q4
$742K Buy
2,595
+1,595
+160% +$411K 0.02% 185
2020
Q3
$336K Buy
+1,000
New +$271K 0.01% 225
2019
Q2
Sell
-38
Closed -$11K 416
2019
Q1
$11K Hold
38
﹤0.01% 407
2018
Q4
$12K Hold
38
﹤0.01% 394
2018
Q3
$15K Hold
38
﹤0.01% 336
2018
Q2
$19K Sell
38
-16
-30% -$10.5K ﹤0.01% 301
2018
Q1
$33K Hold
54
﹤0.01% 291
2017
Q4
$35K Hold
54
﹤0.01% 254
2017
Q3
$40K Hold
54
﹤0.01% 271
2017
Q2
$47K Buy
54
+25
+86% +$26K ﹤0.01% 267
2017
Q1
$35K Hold
29
﹤0.01% 287
2016
Q4
$38K Sell
29
-1
-3% -$1.31K ﹤0.01% 275
2016
Q3
$43K Buy
30
+28
+1,400% +$44K ﹤0.01% 269
2016
Q2
$5K Hold
2
﹤0.01% 321
2016
Q1
$4K Buy
+2
New +$3.1K ﹤0.01% 352

Other funds holding DRIO

Psagot Value Holdings's DRIO Position: Q2 2022 in Review

Psagot Value Holdings sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 2,176 shares — an estimated $254K sold.

Psagot Value Holdings first reported a position in DRIO in Q1 2016 and held it in 17 quarters. The position peaked at $742K in Q4 2020. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • Psagot Value Holdings reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • Psagot Value Holdings sold 2,176 DarioHealth shares in Q2 2022, an estimated $254K.
  • Psagot Value Holdings first reported a position in DarioHealth in Q1 2016 and held it in 17 quarters.
  • Psagot Value Holdings's DarioHealth position peaked at $742K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Psagot Value Holdings's 13F filing for Q2 2022, filed 9 Aug 2022.